Abstract Submission
Please download the abstract submission form at the bottom of the screen and send the completed form to jsp108@gakkai.co.jp by E-mail.
Information required for abstract submission
The first author from domestic institutions must be a member of the Japanese Society of Pathology. Authors who submit abstract from international institutions are not necessary to be a member of the society.
Inquiries regarding membership can be obtained at the Secretariat Office of the Japanese Society of Pathology. The details of the contact can be found at the bottom of the screen.
* Except "Poster presentation - Undergraduate (Undergraduate students)"
(Those who are applying for membership must enter "99" in the "Membership Number" box.)
Abstract submission
Abstract submission has been closed.
Thank you for your submission.
1. Presentation style
Oral presentation (English) |
Oral presentation (Japanese) |
Poster presentation |
Poster presentation - Undergraduate (Undergraduate students) |
Poster presentation – Postgraduate (Trainees) |
Poster presentation – Postgraduate (Postgraduate students・Residents) |
Poster presentation session by undergraduate students, trainees, postgraduate students, and residents will be held particularly on May 11, 2019. Each of the sessions will have five speakers. There will be award for excellent presentation from each session which will be given at the reception time. We look forward to your registration.
*If the above schedule is not suitable, please make registration for general poster presentation session that will be held on May 9, and 10.
Please note that we may ask you to present in a different presentation format from your preferred session at the registration stage.
2. Keywords
*required
Keywords 1 * | |
---|---|
01 | Diagnostic pathology・Human pathology |
02 | Experimental pathology |
03 | Others |
Keywords 2 * | |
---|---|
01 | Interdisciplinary pathology |
02 | Systemic diseases |
03 | Oral cavity・Head and neck・Salivary glands |
04 | Heart |
05 | Vessels |
06 | Respiratory tract |
07 | Mediastinum・Thymus |
08 | Serosal membranes・Mesothelium・Somatic cavity |
09 | Upper gastrointestinal tract |
10 | Lower gastrointestinal tract |
11 | Liver |
12 | Biliary system |
13 | Pancreas |
14 | Breast |
15 | Endocrine organs |
16 | Urinary system |
17 | Male reproductive organs |
18 | Female reproductive organs |
19 | Placenta and perinatal pathology |
20 | Pediatric pathology |
21 | Central nervous system |
22 | Peripheral nervous system |
23 | Bone and soft tissue・Locomotor organs |
24 | Blood・Bone marrow |
25 | Lymph nodes |
26 | Spleen |
27 | Skin |
28 | Sensory organs |
29 | Others |
Keywords 3-1 * | |
---|---|
01 | Neoplastic diseases |
02 | Inflammatory diseases |
03 | Infectious diseases |
04 | Chronic progressive diseases |
05 | Circulatory failure・Circulatory disturbance |
06 | Metabolic disorder・Degenerative disorder |
07 | Transplantation pathology |
08 | Intractable and rare diseases |
09 | Congenital disorder・Developmental anomaly |
10 | Radiation injury |
11 | Autopsy |
12 | Cytodiagnosis |
13 | Intraoperative consultation |
14 | Differential diagnosis |
15 | Immunohistochemistry・Diagnostic molecular pathology |
16 | Classification of Diseases |
17 | Evaluation of treatment effects・Therapeutic strategies |
18 | Epidemiology・Statistics |
19 | Image analysis・Novel technology |
20 | Information technology・Bioinformatics |
21 | Education・Medical staff |
22 | Quality control |
23 | Work-life balance |
24 | Chromosomal abnormality・Hereditary diseases |
25 | Animal disease models |
26 | Genetic risks・Environmental factors |
27 | Genetic mutation・Carcinogenesis |
28 | Gene expression・Epigenetics |
29 | Signal transduction・Cell proliferation・Cell cycle |
30 | Cell death・Cell damage・Senescence |
31 | Invasion and metastasis |
32 | Cancer microenvironment・Cancer stem cells |
33 | Cancer cellular characteristics |
34 | Cancer immunology |
35 | Diagnostic markers・Tumor markers・New therapies |
36 | Cell biology・Molecular imaging |
37 | Cell differentiation・Regenerative medicine |
38 | Development and developmental abnormalities |
39 | Immunity・Inflammation |
40 | Autoimmunity・Autoinflammation |
41 | Others |
Keywords 3-2 for Second Choice |
---|
3. Title
The title must be written in English
Maximum number of characters: 100
*Titles with more than 100 characters cannot be registered.
4. Abstract body
Abstract will be accepted in English only.
Maximum number of characters: 1040
5. Co-author(s) / affiliation(s)
Co-author(s): up to 10 persons including the first author
Affiliation(s): up to 10 institutions
List of abbreviations used for affiliated institutions: page
6. Selection of abstracts
Abstracts selection and presentation type will be reviewed and decided by the program committee.
Notifications of accepted abstract will be sent by e-mail to the authors.
Abstract submission
Download / Abstract Submission Form
Please download this abstract submission form and send the completed form to jsp108@gakkai.co.jp by E-mail.
Point of contact for information on the abstract submission form
Secretariat
Department of Pathology, Keio University School of Medicine
35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
Phone: +81-3-5363-3764 FAX: +81-3-3353-3290
E-mail: jsp108@gakkai.co.jp
Membership inquiries
The Japanese Society of Pathology
1-2-5 Yushima, Seidomae Bldg. 7F Bunkyo-ku, Tokyo 113-0034 Japan
Phone: +81-3-6206-9070 / FAX: +81-3-6206-9077
E-mail: jsp-admin@umin.ac.jp
http://pathology.or.jp/about_jsp/about-jsp.html